Cargando…

Novel Targeted Therapies for T-Cell Malignancies

Detalles Bibliográficos
Autor principal: Tesio, Melania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406054/
https://www.ncbi.nlm.nih.gov/pubmed/36010948
http://dx.doi.org/10.3390/cancers14163955
_version_ 1784774029751615488
author Tesio, Melania
author_facet Tesio, Melania
author_sort Tesio, Melania
collection PubMed
description
format Online
Article
Text
id pubmed-9406054
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94060542022-08-26 Novel Targeted Therapies for T-Cell Malignancies Tesio, Melania Cancers (Basel) Editorial MDPI 2022-08-16 /pmc/articles/PMC9406054/ /pubmed/36010948 http://dx.doi.org/10.3390/cancers14163955 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Tesio, Melania
Novel Targeted Therapies for T-Cell Malignancies
title Novel Targeted Therapies for T-Cell Malignancies
title_full Novel Targeted Therapies for T-Cell Malignancies
title_fullStr Novel Targeted Therapies for T-Cell Malignancies
title_full_unstemmed Novel Targeted Therapies for T-Cell Malignancies
title_short Novel Targeted Therapies for T-Cell Malignancies
title_sort novel targeted therapies for t-cell malignancies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406054/
https://www.ncbi.nlm.nih.gov/pubmed/36010948
http://dx.doi.org/10.3390/cancers14163955
work_keys_str_mv AT tesiomelania noveltargetedtherapiesfortcellmalignancies